We are live on
!
Find out more
PM
Penbrook Management Portfolio holdings
AUM
$157M
1-Year Est. Return
46.57%
This Fund
S&P 500
This Quarter
Est. Return
+40.87%
1 Year Est. Return
+46.57%
3 Year Est. Return
+102.93%
5 Year Est. Return
+150.44%
10 Year Est. Return
–
AUM
$102M
AUM Growth
+$23.6M
(+30%)
Cap. Flow
+$708K
Cap. Flow
% of AUM
0.7%
Top 10 Holdings %
Top 10 Hldgs %
41.2%
Holding
109
New
6
Increased
19
Reduced
18
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vicor
VICR
|
+$505K |
| 2 |
Azenta
AZTA
|
+$498K |
| 3 |
IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
|
+$434K |
| 4 |
USA Compression Partners
USAC
|
+$374K |
| 5 |
Identive
INVE
|
+$261K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CryoPort
CYRX
|
+$631K |
| 2 |
CYBE
Cyberoptics Corp
CYBE
|
+$575K |
| 3 |
AGN
Allergan plc
AGN
|
+$511K |
| 4 |
Fidelity National Information Services
FIS
|
+$234K |
| 5 |
Axcelis
ACLS
|
+$219K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.71% |
| 2 | Healthcare | 17.53% |
| 3 | Financials | 10.01% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 8.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRN
101
DELISTED
Veren
VRN
| $21K | 0.02% |
12,750
-3,200
| -20% | -$4.42K |
|
102
Baytex Energy
BTE
$3.1B
| $19K | 0.02% |
37,930
-7,000
| -16% | -$2.51K |
|
|
103
Fidelity National Information Services
FIS
$23.1B
| – | – |
-1,924
| Closed | -$234K |
|
|
TYG
104
Tortoise Energy Infrastructure Corp
TYG
$1.08B
| – | – |
-4,700
| Closed | -$48K |
|
|
RTW
105
DELISTED
RTW Retailwinds, Inc.
RTW
| – | – |
-298,520
| Closed | -$63K |
|
|
AGN
106
DELISTED
Allergan plc
AGN
| – | – |
-2,886
| Closed | -$511K |
|
Similar funds
IWM
EP
AC
SF
LAM
HAM
HEM
CF
Penbrook Management's Q2 2020 Portfolio in Review
As of Q2 2020, Penbrook Management held 109 positions worth $102M, up 30% from $78.1M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Penbrook Management's Q2 2020 filing shows 6 new, 19 increased, 18 reduced and 6 closed positions. Its largest new stake was Vicor: 9,000 shares worth $648K. The largest sale was CryoPort, an estimated $631K.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- Penbrook Management's largest Q2 2020 buy was Vicor: 9,000 shares worth $648K.
- Penbrook Management added most to Azenta in Q2 2020, an estimated $498K increase.
- Penbrook Management's biggest Q2 2020 reduction was CryoPort, cutting an estimated $631K.
- Penbrook Management fully exited Allergan plc in Q2 2020, selling an estimated $511K.
- Penbrook Management's ten largest holdings make up 41% of its $102M portfolio in Q2 2020.
- Penbrook Management opened 6 new positions and closed 6 in Q2 2020.
- Penbrook Management's portfolio value rose 30% quarter-over-quarter to $102M.
Based on Penbrook Management's 13F filing for Q2 2020, filed 28 Jul 2020.